Immunological mechanisms associated with long-term remission of human type1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 3, 2006, Pages 184-189

  Karges, Beate ^a   Durinovic Belló, Ivana ^b   Heinze, Eberhard ^a   Debatin, Klaus Michael ^a   Boehm, Bernhard ^b   Karges, Wolfram ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Autoimmunity; Beta cell; Remission; T cells; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD45RA ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INSULIN; INSULIN ANTIBODY; INTERLEUKIN 10; PARIETAL CELL ANTIBODY; PEPTIDE LIBRARY; PREPROINSULIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1A2; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HELPER CELL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOREGULATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOLECULAR RECOGNITION; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-10; ISLETS OF LANGERHANS; LEUKOCYTES, MONONUCLEAR; MALE; REMISSION, SPONTANEOUS; TIME FACTORS;

EID: 33744464264     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.600     Document Type: Article

References (23)

1. Knip M, Sakkinen A, Huttunen NP, et al. Postinitial remission in diabetic children-an analysis of 178 cases. Acta Paediatr Scand 1982; 71: 901-908.
2. Ortqvist E, Falorni A, Scheynius A, Persson B, Lernmark A. Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. Acta Paediatr 1997; 86: 1166-1171.
3. Muhammad BJ, Swift PG, Raymond NT, Botha JL. Partial remission phase of diabetes in children younger than age 10 years. Arch Dis Child 1999; 80: 367-369.
4. Karlsson FA, Bjork E. Beta-cell rest: a strategy for the prevention of autoimmune diabetes. Autoimmunity 1997; 26: 117-122.
5. Buyukgebiz A, Cemeroglu AP, Bober E, Mohn A, Chiarelli F. Factors influencing remission phase in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001; 14: 1585-1596.
6. Kordonouri O, Danne T, Enders I, Weber B. Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? results of the Berlin retinopathy study. Eur J Pediatr 1998; 157: 202-207.
7. Scholin A, Berne C, Schvarcz E, Karlsson FA, Bjork E. Factors predicting clinical remission in adult patients with type 1 diabetes. J Intern Med 1999; 245: 155-162.
8. Couzin J. Clinical trials. Diabetes' brave new world. Science 2003; 300: 1862-1865.
9. Karges B, Durinovic Bello I, Heinze E, Boehm BO, Debatin KM, Karges W. Complete long term recovery of beta cell function in autoimmune type 1 diabetes after insulin treatment. Diabetes Care 2004; 27: 1207-1208.
10. Durinovic-Bello I, Schlosser M, Riedl M, et al. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRBl*04, DQ8 Type 1 diabetes. Diabetologia 2004; 47: 439-450.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
13. Heinze E, Horn T, Wabitsch M, Wudy S, Sorgo W, Homoki J. Measurement of insulin resistance and insulin sensitivity in children and adolescents. Monatsschr Kinderheilkd 2002; 150: 1095-1100.
14. Durinovic-Bello I, Boehm BO, Ziegler AG. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity. J Autoimmun 2002; 18: 55-66.
15. Arif S, Tree TI, Astill TP, et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113: 451-463.
16. Eisenbarth GS, Jasinski JM. Disease prevention with islet autoantigens. Endocrinol Metab Clin North Am 2004; 33: 59-73, viii.
17. Nepom GT. Class II antigens and disease susceptibility. Annu Rev Med 1995; 46: 17-25.
18. Martin S, Pawlowski B, Greulich B, Ziegler AG, Mandrup-Poulsen T, Mahon J. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care 1992; 15: 66-74.
19. Diabetes Prevention Trial-Type 1 Diabetes Study G. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685-1691.
20. Karges W, Pechhold K, Al-Dahouk S, et al. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice. Diabetes 2002; 51: 3237-3244.
21. Pietropaolo M, Eisenbarth GS. Autoantibodies in human diabetes. Curr Dir Autoimmun 2001; 4: 252-282.
22. Peterson LD, van der Keur M, de Vries RR, Roep BO. Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia 1999; 42: 443-449.
23. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182: 68-79.